BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26047632)

  • 1. Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients.
    Pesce F; Diciolla M; Binetti G; Naso D; Ostuni VC; Di Noia T; Vågane AM; Bjørneklett R; Suzuki H; Tomino Y; Di Sciascio E; Schena FP
    Nephrol Dial Transplant; 2016 Jan; 31(1):80-6. PubMed ID: 26047632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient classification and outcome prediction in IgA nephropathy.
    Diciolla M; Binetti G; Di Noia T; Pesce F; Schena FP; Vågane AM; Bjørneklett R; Suzuki H; Tomino Y; Naso D
    Comput Biol Med; 2015 Nov; 66():278-86. PubMed ID: 26453758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of ESRD in IgA Nephropathy Patients from an Asian Cohort: A Random Forest Model.
    Liu Y; Zhang Y; Liu D; Tan X; Tang X; Zhang F; Xia M; Chen G; He L; Zhou L; Zhu X; Liu H
    Kidney Blood Press Res; 2018; 43(6):1852-1864. PubMed ID: 30537719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease.
    Komatsu H; Fujimoto S; Kikuchi M; Sato Y; Kitamura K
    Ren Fail; 2012; 34(4):448-53. PubMed ID: 22260382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up.
    Haaskjold YL; Lura NG; Bjørneklett R; Bostad L; Bostad LS; Knoop T
    Nephrol Dial Transplant; 2023 May; 38(5):1183-1191. PubMed ID: 35904322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.
    Rauta V; Finne P; Fagerudd J; Rosenlöf K; Törnroth T; Grönhagen-Riska C
    Clin Nephrol; 2002 Aug; 58(2):85-94. PubMed ID: 12227693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
    Knoop T; Vågane AM; Vikse BE; Svarstad E; Magnúsdóttir BT; Leh S; Varberg Reisæter A; Bjørneklett R
    Am J Nephrol; 2015; 41(3):210-9. PubMed ID: 25872002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy.
    Thompson A; Carroll K; A Inker L; Floege J; Perkovic V; Boyer-Suavet S; W Major R; I Schimpf J; Barratt J; Cattran DC; S Gillespie B; Kausz A; W Mercer A; Reich HN; H Rovin B; West M; Nachman PH
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):469-481. PubMed ID: 30635299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
    Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
    Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroids pulse therapy and oral corticosteroids therapy for IgA nephropathy patients with advanced chronic kidney disease: results of a multicenter, large-scale, long-term observational cohort study.
    Tsunoda R; Usui J; Hoshino J; Fujii T; Suzuki S; Takaichi K; Ubara Y; Yamagata K
    BMC Nephrol; 2018 Sep; 19(1):222. PubMed ID: 30189860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy.
    Schena FP; Anelli VW; Trotta J; Di Noia T; Manno C; Tripepi G; D'Arrigo G; Chesnaye NC; Russo ML; Stangou M; Papagianni A; Zoccali C; Tesar V; Coppo R;
    Kidney Int; 2021 May; 99(5):1179-1188. PubMed ID: 32889014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
    Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association of Low Hemoglobin Levels with IgA Nephropathy Progression: A Two-Center Cohort Study of 1,828 Cases.
    Zhu B; Liu WH; Yu DR; Lin Y; Li Q; Tong ML; Li YY; Yang RC; Du YY; Tang XL; Jiang F; Fei D; Wei XY; Zhang FF; Yin JZ; Wang WR; Li XF; Sun Y; Zhong YZ; Zhang MJ; Cheng XX; Zhu CF; Chen HY
    Am J Nephrol; 2020; 51(8):624-634. PubMed ID: 32694247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy.
    Donadio JV; Bergstralh EJ; Grande JP; Rademcher DM
    Nephrol Dial Transplant; 2002 Jul; 17(7):1197-203. PubMed ID: 12105241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Uric Acid Level Predicts Progression of IgA Nephropathy in Females but Not in Males.
    Nagasawa Y; Yamamoto R; Shoji T; Shinzawa M; Hasuike Y; Nagatoya K; Yamauchi A; Hayashi T; Kuragano T; Moriyama T; Isaka Y; Nakanishi T
    PLoS One; 2016; 11(8):e0160828. PubMed ID: 27560997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients.
    Jiang Z; Tan J; Wang S; Dong L; Han X; Tang Y; Qin W
    Int J Med Sci; 2021; 18(13):2964-2970. PubMed ID: 34220324
    [No Abstract]   [Full Text] [Related]  

  • 18. Machine learning in predicting
    Xu LL; Zhang D; Weng HY; Wang LZ; Chen RY; Chen G; Shi SF; Liu LJ; Zhong XH; Hong SD; Duan LX; Lv JC; Zhou XJ; Zhang H
    Front Immunol; 2023; 14():1224631. PubMed ID: 37600788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study.
    Rehnberg J; Symreng A; Ludvigsson JF; Emilsson L
    J Am Soc Nephrol; 2021 Feb; 32(2):411-423. PubMed ID: 33177116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
    Xie J; Lv J; Wang W; Li G; Liu Z; Chen H; Xu F; Sun J; Ouyang Y; Zhang X; Yang M; Shi M; Zhang W; Ren H; Kiryluk K; Zhang H; Chen N
    Am J Kidney Dis; 2018 Sep; 72(3):371-380. PubMed ID: 29555434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.